These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. [Interference of P1290 P polymorphism (4002 A--> G) in molecular diagnosis of mucoviscidosis using the cystic fibrosis assay: an example of a diagnostic trap]. Bienvenu T; Bousquet S; Souville I; Beldjord C Ann Biol Clin (Paris); 1999; 57(6):741-2. PubMed ID: 10572229 [No Abstract] [Full Text] [Related]
16. Cystic fibrosis mutation frequencies in an Irish population. Devaney J; Glennon M; Farrell G; Ruttledge M; Smith T; Houghton JA; Maher M Clin Genet; 2003 Feb; 63(2):121-5. PubMed ID: 12630958 [TBL] [Abstract][Full Text] [Related]
17. Cystic fibrosis: a further case of an asymptomatic compound heterozygote. White SM; Lucassen A; Norbury G Am J Med Genet; 2001 Nov; 103(4):342-3. PubMed ID: 11746017 [No Abstract] [Full Text] [Related]
18. Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein. Riordan JR Am J Hum Genet; 1999 Jun; 64(6):1499-504. PubMed ID: 10330337 [No Abstract] [Full Text] [Related]
19. French CF family genotype analysis shows that the R297Q mutation is a rare polymorphism. Dorval I; Jézéquel P; Chauvel B; Dubourg C; Fergelot P; Le Gall JY; Roussey M; Blayau M Hum Mutat; 1995; 6(4):334-5. PubMed ID: 8680407 [TBL] [Abstract][Full Text] [Related]
20. Cystic fibrosis and bone disease: defective osteoblast maturation with the F508del mutation in cystic fibrosis transmembrane conductance regulator. Velard F; Delion M; Le Henaff C; Guillaume C; Gangloff S; Jacquot J; Tabary O; Touqui L; Barthes F; Sermet-Gaudelus I Am J Respir Crit Care Med; 2014 Mar; 189(6):746-8. PubMed ID: 24628315 [No Abstract] [Full Text] [Related] [Next] [New Search]